Assuntos
Infecções por Ascaridida/diagnóstico , Cegueira/parasitologia , Larva Migrans/diagnóstico , Meningite/diagnóstico , Transtornos Psicomotores/parasitologia , Infecções por Ascaridida/tratamento farmacológico , Encéfalo/diagnóstico por imagem , Pré-Escolar , Diagnóstico Diferencial , Feminino , Granuloma/tratamento farmacológico , Granuloma/parasitologia , Humanos , Larva Migrans/tratamento farmacológico , Imageamento por Ressonância Magnética , Meningite/tratamento farmacológico , Doenças do Nervo Óptico/tratamento farmacológico , Doenças do Nervo Óptico/parasitologiaRESUMO
Bronchiolitis is among the most common illnesses in infants and children, and is the most common cause for hospitalization in infants in the U.S. This illness can be caused by many viruses, most commonly respiratory syncytial virus. It is diagnosed clinically by history and physical exam findings, with a narrow role for ancillary testing. Management is supportive, with medications demonstrating limited utility in multiple studies. Preventive measures include hand hygiene, breastfeeding, avoiding tobacco smoke exposure, and isolation precautions for hospitalized patients. Palivizumab prophylaxis is recommended for infants with qualifying high risk conditions. Recent evidence-based clinical practice guidelines have been published by the American Academy of Pediatrics to guide diagnosis, treatment, and prevention of bronchiolitis.
Assuntos
Bronquiolite Viral , Antivirais/uso terapêutico , Bronquiolite Viral/diagnóstico , Bronquiolite Viral/tratamento farmacológico , Bronquiolite Viral/prevenção & controle , Criança , Hospitalização , Humanos , Lactente , Palivizumab/uso terapêutico , Infecções por Vírus Respiratório Sincicial/complicaçõesRESUMO
Barrier elements that are able to block the propagation of transcriptional silencing in yeast are functionally similar to chromatin boundary/insulator elements in metazoans that delimit functional chromosomal domains. We show that the upstream activating sequences of many highly expressed ribosome protein genes and glycolytic genes exhibit barrier activity. Analyses of these barriers indicate that binding sites for transcriptional regulators Rap1p, Abf1p, Reb1p, Adr1p and Gcn4p may participate in barrier function. We also present evidence suggesting that Rap1p is directly involved in barrier activity, and its barrier function correlates with local changes in chromatin structure. We further demonstrate that tethering the transcriptional activation domain of Rap1p to DNA is sufficient to recapitulate barrier activity. Moreover, targeting the activation domain of Adr1p or Gcn4p also establishes a barrier to silencing. These results support the notion that transcriptional regulators could also participate in delimiting functional domains in the genome.